Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited)

v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses        
Research and development $ 67,291 $ 88,550 $ 92,291 $ 241,302
General and administrative 978,329 673,080 3,284,880 2,631,408
Total operating expenses 1,045,620 761,630 3,377,171 2,872,710
Operating loss (1,045,620) (761,630) (3,377,171) (2,872,710)
Other expense (income)        
Change in fair value of warrant liabilities 1,050,729 (281,497) 1,468,477 (320,495)
Fair value of warrant liability in excess of proceeds     7,174,634  
Change in fair value of conversion rights of Series B preferred stock       (88,532)
Change in fair value of conversion rights of convertible debt     185,000  
Financing transaction costs     137,192  
Loss on extinguishment of convertible debt     590,392  
Amortization of convertible debt discount     34,608  
Interest expense     3,100  
Interest income     (74)  
Loss before income taxes (2,096,349) (480,133) (12,970,500) (2,463,683)
Provision for income taxes     1,642 2,431
Net loss and comprehensive loss (2,096,349) (480,133) (12,972,142) (2,466,114)
Less: Preferred deemed dividend       711,000
Net loss applicable to common shareholders $ (2,096,349) $ (480,133) $ (12,972,142) $ (3,177,114)
Basic earnings per common share (in dollars per share) $ (0.02) $ (0.02) $ (0.11) $ (0.12)
Diluted earnings per common share (in dollars per share) $ (0.02) $ (0.02) $ (0.11) $ (0.12)
Weighted average shares of common stock outstanding        
Basic (in shares) 131,445,057 30,191,744 117,434,563 27,068,308
Diluted (in shares) 131,445,057 30,191,744 117,434,563 27,068,308